1. Home
  2. RVP vs INAB Comparison

RVP vs INAB Comparison

Compare RVP & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVP
  • INAB
  • Stock Information
  • Founded
  • RVP 1994
  • INAB 2016
  • Country
  • RVP United States
  • INAB United States
  • Employees
  • RVP N/A
  • INAB N/A
  • Industry
  • RVP Medical/Dental Instruments
  • INAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVP Health Care
  • INAB Health Care
  • Exchange
  • RVP Nasdaq
  • INAB Nasdaq
  • Market Cap
  • RVP 23.0M
  • INAB 18.8M
  • IPO Year
  • RVP 2001
  • INAB 2021
  • Fundamental
  • Price
  • RVP $0.75
  • INAB $0.23
  • Analyst Decision
  • RVP
  • INAB Strong Buy
  • Analyst Count
  • RVP 0
  • INAB 3
  • Target Price
  • RVP N/A
  • INAB $5.57
  • AVG Volume (30 Days)
  • RVP 49.7K
  • INAB 3.1M
  • Earning Date
  • RVP 03-28-2025
  • INAB 05-08-2025
  • Dividend Yield
  • RVP N/A
  • INAB N/A
  • EPS Growth
  • RVP N/A
  • INAB N/A
  • EPS
  • RVP N/A
  • INAB N/A
  • Revenue
  • RVP $38,265,097.00
  • INAB N/A
  • Revenue This Year
  • RVP N/A
  • INAB N/A
  • Revenue Next Year
  • RVP N/A
  • INAB N/A
  • P/E Ratio
  • RVP N/A
  • INAB N/A
  • Revenue Growth
  • RVP N/A
  • INAB N/A
  • 52 Week Low
  • RVP $0.56
  • INAB $0.22
  • 52 Week High
  • RVP $1.23
  • INAB $1.74
  • Technical
  • Relative Strength Index (RSI)
  • RVP 44.34
  • INAB 38.50
  • Support Level
  • RVP $0.69
  • INAB $0.23
  • Resistance Level
  • RVP $0.83
  • INAB $0.25
  • Average True Range (ATR)
  • RVP 0.06
  • INAB 0.02
  • MACD
  • RVP -0.01
  • INAB -0.00
  • Stochastic Oscillator
  • RVP 34.37
  • INAB 11.40

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: